John Catanzaro
1 min readJan 17, 2019

--

William B. Coley Father of Modern Day Immunotherapy

2019 John A. Catanzaro

William B. Coley, properly, “Father of Modern Day Immunotherapy,” was not accepted by his colleagues and experienced extreme opposition and ridicule. When your work doesn’t fit in the current landscape for whatever reason, maybe ahead of its time, too novel of an innovation, doesn’t follow the rules, attracts the wrong attention or ridiculed and then stolen. You must carry on! Here is a really good journal coverage written in 2003 in British Medical Journal on William B. Coley’s focus.

https://pmj.bmj.com/content/79/938/672

--

--

John Catanzaro

John A. Catanzaro is CEO of Neo7logix, a bioscience company that designs precision and personalized treatment designs. www.neo7logix.com